Lung cancer in Europe: The way forward
Tob Prev Cessat
.
2022 Feb 15:8:06.
doi: 10.18332/tpc/146645.
eCollection 2022.
Authors
Monica Racovita
1
,
Eleanor Wheeler
1
,
Suzanne Wait
1
,
Dani Bancroft
1
,
Rowan Eastabrook
1
,
Tit Albreht
2
3
,
Anne-Marie Baird
4
5
,
Jacek Jassem
6
,
Aoife McNamara
7
8
,
Silvia Novello
9
10
,
Cornel Radu-Loghin
11
,
Jan P van Meerbeeck
12
13
14
Affiliations
1
The Health Policy Partnership, London, United Kingdom.
2
Department of Public Health, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.
3
National Institute of Public Health of Slovenia, Ljubljana, Slovenia.
4
Lung Cancer Europe, Bern, Switzerland.
5
School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.
6
Medical University of Gdańsk, Gdańsk, Poland.
7
Global Lung Cancer Coalition, Dublin, Ireland.
8
Irish Cancer Society, Dublin, Ireland.
9
Women Against Lung Cancer in Europe, Turin, Italy.
10
Department of Oncology, San Luigi Hospital, University of Turin, Turin, Italy.
11
European Network for Smoking and Tobacco Prevention, Brussels, Belgium.
12
European Cancer Organisation, Brussels, Belgium.
13
European Respiratory Society, Lausanne, Switzerland.
14
Oncology Department, Antwerp University Hospital, Antwerp, Belgium.
PMID:
35233474
PMCID:
PMC8845476
DOI:
10.18332/tpc/146645
No abstract available
Keywords:
COVID-19; Europe; lung cancer; non-communicable diseases; screening; treatment.
Publication types
Editorial